Hoth Therapeutics, Inc.
HOTH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $15,421 | $127 | $5,454 |
| - Cash | $7,848 | $9,014 | $11,317 | $7,039 |
| + Debt | $0 | $21 | $29 | $31 |
| Enterprise Value | – | $6,428 | -$11,161 | -$1,554 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,106 | -$2,199 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$4,106 | -$2,199 | -$3,476 | -$2,383 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.17 | -0.36 | -0.33 |
| % Growth | -76.5% | 52.8% | -9.1% | – |
| Operating Cash Flow | -$2,493 | -$2,373 | -$2,788 | -$2,028 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$2,493 | -$2,373 | -$2,788 | -$2,028 |